BIOY GraniteShares YieldBOOST Biotech ETF
Quote as of Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 21.38 | Day Range | 21.39 – 21.47 |
| 52-Week Range | 20.66 – 25.28 | Volume | 2.10K |
| Avg Volume | 1.89K | AUM | $855.4K (Aug 27, 2026) |
| Expense Ratio | 1.07% | Yield (TTM) | 19.53% |
| NAV | 21.38 | Premium/Discount | +0.23% indicative |
| Inception | May 05, 2026 | Holdings | — |
| Issuer | GraniteShares | Exchange | NASDAQ |
| Category | Biotech | Index Tracked | Not stated in source data |
| CUSIP | 38747T641 | ISIN | US38747T6414 |
| Management | Not stated in source data | ||
About this ETF
The GraniteShares YieldBOOST Biotech ETF, an exchange-traded fund launched by GraniteShares Inc. under the umbrella of the GraniteShares ETF Trust, is managed by GraniteShares Advisors LLC. This U.S.-domiciled fund primarily allocates capital to the public stock markets within the United States. Its investment approach involves constructing its portfolio using derivative instruments, such as options, to gain exposure to companies operating across the healthcare, pharmaceutical, biotechnology, and life sciences industries. The ETF seeks a diverse selection of both growth and value stocks, encompassing businesses of varying market capitalizations.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +0.47% | -10.83% | — | — | — | — | — | — | -14.46% |
| Total return | +3.98% | +1.09% | — | — | — | — | — | — | +0.38% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 1.07% | Annual cost of a $10,000 investment | $107.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 22, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 7 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | US TBill 10/22/2026 | — | 47.13% | 400.00K | $397.5K |
| 2 | US Dollars | — | 41.62% | 351.05K | $351.1K |
| 3 | US TBill 02/04/2027 | — | 11.65% | 100.00K | $98.3K |
| 4 | 2LABU 08/24/2026 P258.57 | — | 0.24% | 20 | $2.0K |
| 5 | 2LABU 08/21/2026 P248.89 | — | 0.00% | 10 | $19.84 |
| 6 | 2LABU 08/21/2026 P262.71 | — | -0.02% | -10 | -$128.52 |
| 7 | 2LABU 08/24/2026 P272.94 | — | -0.63% | -20 | -$5.3K |
Click a ticker to see every ETF that owns it.
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 19.53% | Paid (last 12 months) | $4.1818 |
| Frequency | Weekly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Aug 21, 2026 | Last payment | $0.2490 (Aug 25, 2026) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Aug 21, 2026 | Aug 21, 2026 | Aug 25, 2026 | $0.2490 |
| Aug 14, 2026 | Aug 14, 2026 | Aug 18, 2026 | $0.2451 |
| Aug 07, 2026 | Aug 07, 2026 | Aug 11, 2026 | $0.2373 |
| Jul 31, 2026 | Jul 31, 2026 | Aug 04, 2026 | $0.2395 |
| Jul 24, 2026 | Jul 24, 2026 | Jul 28, 2026 | $0.2516 |
| Jul 17, 2026 | Jul 17, 2026 | Jul 21, 2026 | $0.2480 |
| Jul 10, 2026 | Jul 10, 2026 | Jul 14, 2026 | $0.2622 |
| Jul 02, 2026 | Jul 02, 2026 | Jul 07, 2026 | $0.2601 |
| Jun 26, 2026 | Jun 26, 2026 | Jun 30, 2026 | $0.2701 |
| Jun 18, 2026 | Jun 18, 2026 | Jun 23, 2026 | $0.2665 |
| Jun 12, 2026 | Jun 12, 2026 | Jun 16, 2026 | $0.2621 |
| Jun 05, 2026 | Jun 05, 2026 | Jun 09, 2026 | $0.2676 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
Liquidity
| Volume today | 2.10K | Average volume | 1.89K |
| AUM | $855.4K | Premium/Discount | +0.23% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | -$42.00 | -0.01% | $846.1K → $846.1K |
| 1 Week | -$539.00 | -0.06% | $847.0K → $846.1K |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for BIOY
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.